With the new maintenance and reliever therapy (MART) license for children, this simple guide provides information and guidance on introducing children of 5-11 years of age safely and effectively to a MART regimen. It covers:
This document offers practical guidance on delivering evidence-based asthma care, particularly when it takes place in unplanned care settings.It focuses on the management of asthma in adults and young people aged 12 and over.
In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 and then again in 2023 known as ‘Keeping it S
The BTS/NICE/SIGN asthma guidelines now recommend moving away from blue (reliever) and brown (preventer) inhalers. Many people with asthma still rely on their blue inhaler despite the fact they:
Anti-inflammatory reliever (AIR) is a single inhaler treatment for asthma which can be used by people with asthma and who experience asthma symptoms twice a week or less. It removes the need to have separate preventer (brown) and reliever (blue) inhalers.
This document is a distillation of the new guidance to provide distinct advice on the changes on the diagnosis and management to asthma. It is not intended to be a comprehensive guide of the new guideline, neither does it cover all non-pharmacological treatments or on-going monitoring.
Now is the time to make MART moves for asthma.
Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways.
Knowing how to use Very Brief Advice to instigate a quit attempt and supporting smokers who are ready to quit is the business of every healthcare professional.Treating tobacco dependency systematically and effectively will have a significant impact on the triple aim:
In this article Anthony Ball and Rachel Williams provide a summary of why it is so important to address poor housing as a way of tackling health inequalities.
Digital technology aims to improve access to healthcare. However, for certain individuals with respiratory conditions, it may introduce additional barriers rather than eliminating existing ones.
This article aims to support healthcare professionals working within general practice to implement Ten ways to implement sustainable greener healthcare in primary care respiratory practice, a publication from the Primary Care Respiratory Society (PCRS).
The UK Inhaler Group (UKIG) has produced a practical concise guide to support healthcare professionals in selecting and using spacer and valved holding chamber (VHC) devices for patients with asthma and COPD.
Asthma is a long term condition caused by inflammation of the airways leading to wheeze, cough, breathlessness and chest tightness. It is the most common chronic condition in childhood, affecting around 1.1 million children in the UK, equivalent to three children in every classroom.